These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
455 related items for PubMed ID: 15679485
1. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME. Clin Microbiol Infect; 2005 Feb; 11(2):115-21. PubMed ID: 15679485 [Abstract] [Full Text] [Related]
2. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Michalopoulos A, Kasiakou SK, Mastora Z, Rellos K, Kapaskelis AM, Falagas ME. Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967 [Abstract] [Full Text] [Related]
3. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study. Michalopoulos A, Fotakis D, Virtzili S, Vletsas C, Raftopoulou S, Mastora Z, Falagas ME. Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758 [Abstract] [Full Text] [Related]
4. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Falagas ME, Rafailidis PI, Ioannidou E, Alexiou VG, Matthaiou DK, Karageorgopoulos DE, Kapaskelis A, Nikita D, Michalopoulos A. Int J Antimicrob Agents; 2010 Feb; 35(2):194-9. PubMed ID: 20006471 [Abstract] [Full Text] [Related]
5. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii. Motaouakkil S, Charra B, Hachimi A, Nejmi H, Benslama A, Elmdaghri N, Belabbes H, Benbachir M. J Infect; 2006 Oct; 53(4):274-8. PubMed ID: 16442632 [Abstract] [Full Text] [Related]
6. Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis. Falagas ME, Sideri G, Vouloumanou EK, Papadatos JH, Kafetzis DA. Pediatr Infect Dis J; 2009 Feb; 28(2):123-7. PubMed ID: 19116601 [Abstract] [Full Text] [Related]
7. [Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii]. Taşbakan MS, Pullukçu H, Ekren PK, Oz AT, Midilli M, Aydemir S, Gürgün A, Başoğlu OK, Bacakoğlu F. Mikrobiyol Bul; 2009 Jan; 43(1):61-70. PubMed ID: 19334381 [Abstract] [Full Text] [Related]
12. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU. Kallel H, Bahloul M, Hergafi L, Akrout M, Ketata W, Chelly H, Hamida CB, Rekik N, Hammami A, Bouaziz M. Int J Antimicrob Agents; 2006 Oct; 28(4):366-9. PubMed ID: 16971093 [Abstract] [Full Text] [Related]
13. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections. Cheng CY, Sheng WH, Wang JT, Chen YC, Chang SC. Int J Antimicrob Agents; 2010 Mar; 35(3):297-300. PubMed ID: 20045293 [Abstract] [Full Text] [Related]
14. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series. Falagas ME, Siempos II, Rafailidis PI, Korbila IP, Ioannidou E, Michalopoulos A. Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994 [Abstract] [Full Text] [Related]